SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
IMRX

Immuneering Corp (IMRX)

NASDAQ: IMRX · Real-Time Price · USD
Healthcare · Biotechnology
$3.52-$0.19 (-5.12%)
 
Market cap
$228M
Insider Score
Analyst consensus
Insider Score
80/ 100
IMRX Insider Score
Bullish

1 qualifying trade · 1 insider · $89.50K bought in the last 90 days

IMRX Income Statement

Fiscal PeriodQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Period EndingSep 30, 2026Jun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025
Revenue$0.00$0.00$0.00$0.00$0.00
Revenue Growth (YoY)—————
Cost of Revenue—————
Gross Profit—————
SG&A Expense$5.06 M$5.00 M$4.68 M$4.49 M$4.50 M
R&D Expense$20.72 M$14.00 M$10.65 M$9.25 M$10.87 M
Operating Expenses$25.79 M$19.00 M$15.33 M$13.75 M$15.38 M
Operating Income-$25.79 M-$19.00 M-$15.33 M-$13.75 M-$15.38 M
Pretax Income-$24.19 M-$17.27 M-$13.46 M-$11.58 M-$14.96 M
Tax Provision—————
Net Income-$24.19 M-$17.27 M-$13.46 M-$11.58 M-$14.96 M
EPS (Basic)-$0.37-$0.27-$0.21-$0.18-$0.38
EPS (Diluted)-$0.37-$0.27-$0.21-$0.18-$0.38
Shares Outstanding64.71 M64.70 M64.66 M64.59 M39.67 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Immuneering Corp (IMRX) Financials: Revenue, Earnings & Balance Sheet | InsiderBuying.com